Classement en actions
#32515
Pharmena S.A. engages in the sale of dietary supplements in Poland and... Pharmena S.A. engages in the sale of dietary supplements in Poland and internationally. It also develops 1-MNA (PHR-701 program), a medical device for use in difficult-to-heal wounds. In addition, the company is involved in research and development of therapeutic applications of 1 MNA as an anti-inflammatory and anti-fibrotic drug; and research and development at pulmonary fibrosis, respiratory tract infections, including viral infections, COVID-19, inflammatory diseases, metabolic diseases and other therapeutic applications. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. operates as a subsidiary of Pelion S.A.
Prix de l'action
$0.88679187
Capitalisation boursière
$9.88M
Changement (1 jour)
-1.56%
Échange Pharmena S.a. (PHR)
Le prix PHR avec la capitalisation boursière de B
Capitalisation boursière de Pharmena S.a.(PHR)
Capitalisation boursière: $9.88M
En August 2026, Pharmena S.a. a une capitalisation boursière de $9.88M. Cela fait de Pharmena S.a. la 32515th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Pharmena S.a. du 2008 au 2026
PHR par rapport au top 5 des plus populaires stocks
| Prix pour PHR |
|
L’actif B |
La capitalisation boursière de B |
Résultats |
|
|
|
|
$5.460T
|
+55,281,968.54%
|
|
|
|
|
$4.489T
|
+45,454,407.56%
|
|
|
|
|
$4.141T
|
+41,925,023.08%
|
|
|
|
|
$3.569T
|
+36,130,097.11%
|
|
|
|
|
$2.798T
|
+28,328,999.74%
|
